Retinal imaging tests for microvascular functions

微血管功能的视网膜成像测试

基本信息

  • 批准号:
    6576258
  • 负责人:
  • 金额:
    $ 16.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2004-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Microvascular abnormalities and pathologies occur in all the tissues and organs of diabetic patients. Cellular abnormalities in the microvessels extend to both vascular cells and innervation surrounding the microvasculature. We suggest that microvascular diseases in the retina and those in the skin or peripheral tissues may share many common characteristics in early stages of diabetes. Thus, imaging techniques to assess both vascular and neurological functions via the retina may be helpful to diagnose and quantitate microvascular and neurological damage in the periphery. This postulate is based on the fact that clinically, diabetic retinopathy and sensory polyneuropathy (DPN), occurs frequently together. Functional studies have shown that blood flow is decreased in the retina and peripheral nerve early in the course of diabetes. Common pathologies for both tissues include pericyte loss, basal membrane thickening, capillary dropouts and microaneurysms. Thus, imaging tests that could directly assess retinal microvascular dysfunction and sensory abnormalities in diabetic patients may also detect peripheral microvascularopathy and sensory neuropathy at earlier time since it is much easier to visualize retinal microvasculature and potentially neurological functions than the microvessels of the skin or nerves. In collaboration with Dr. Veves and Dr. Bursell, we have developed a series of retinal and systemic microvascular function tests to evaluate their possible use for the diagnosis of microvascular disease in diabetic patients. The retinal function tests are: digitalized retinal video fluorescein angiogram (VFA) for quantitating microvascular flow; retinal oximetry (RO) for measuring oxygen saturation; and electroretinogram (ERG) for measuring neural-retina functions. The results from these retinal functions will be correlated to peripheral microvascular and sensory function tests which will include neuropathy sensory score (NSS), neuropathy disability score (NDS) and quantitative sensory testing (QST) and nerve axonal reflex (NAR) for measuring sensory fiber abnormalities and skin blood flow by laser Doppler flowmetry. The specific aims for this grant are: 1) to determine in control and non-diabetic subjects from 18-35 years of age, the normal range for changes in VFA, RO and ERG and several neural vascular function tests such as NSS, NDS, QST, nerve axonal reflex and skin blood flow by laser Doppler both breathing room air and 12 percent and 100 percent oxygen (O2) in the breathing air; 2) to assess correlation between retinal, neural and microvascular changes by ERG, VFA and RO and peripheral microvascular and sensory functions as described in specific aim 1 in Type 1 diabetic patients with no or minimal retinopathy, moderate and severe non-proliferative diabetic retinopathy. These studies should provide us with information on whether retinal neural and vascular imaging function tests can be related to peripheral neural and microvascular dysfunctions and pathologies in diabetic patients.
描述(由申请人提供):糖尿病患者的所有组织和器官都会发生微血管异常和病理。微血管中的细胞异常延伸至微脉管系统周围的血管细胞和神经。我们建议,视网膜和皮肤或周围组织中的微血管疾病可能在糖尿病的早期阶段具有许多常见特征。因此,通过视网膜评估血管和神经功能的成像技术可能有助于诊断和定量周围的微血管和神经系统损害。这一假设是基于以下事实:临床,糖尿病性视网膜病和感觉多神经病(DPN)经常一起发生。功能研究表明,在糖尿病过程中,视网膜和周围神经的血流减少。两种组织的常见病理包括周细胞损失,基底膜增厚,毛细血管辍学和微型干扰瘤。因此,糖尿病患者中可以直接评估视网膜微血管功能障碍和感觉异常的成像测试也可能在早期检测到周围的微血管病和感觉神经病,因为比起皮肤或皮肤的微量蛋白质,可视化视网膜微血管和潜在的神经功能要容易得多。与Veves博士和Bursell博士合作,我们开发了一系列视网膜和系统的微血管功能测试,以评估它们在糖尿病患者中可能使用的微血管疾病。视网膜功能测试是:数字化视网膜视频荧光素血管造影(VFA),用于定量微血管流动;用于测量氧饱和度的视网膜血清法(RO);和电子图(ERG),用于测量神经疗法功能。 The results from these retinal functions will be correlated to peripheral microvascular and sensory function tests which will include neuropathy sensory score (NSS), neuropathy disability score (NDS) and quantitative sensory testing (QST) and nerve axonal reflex (NAR) for measuring sensory fiber abnormalities and skin blood flow by laser Doppler flowmetry.该赠款的具体目的是:1)确定从18-35岁的对照和非糖尿病受试者确定,VFA,RO和ERG的变化的正常范围以及几种神经血管功能测试,NSS,NDS,NDS,QST,QST,神经轴突反射和皮肤血液流动均由激光多普勒的呼吸室和12%的OXY(OOX)(OY2%)(OE 100%)(OO2)(OO2)。 2)评估ERG,VFA和RO的视网膜,神经和微血管变化之间的相关性,以及外周的微血管和感觉功能,如1型1型糖尿病患者中所述,无视网膜病,中度和严重的非增生性非增生性糖尿病性糖尿病性视网膜病。这些研究应为我们提供有关视网膜神经和血管成像功能测试是否与糖尿病患者的周围神经和微血管功能障碍和病理学相关的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE L KING其他文献

GEORGE L KING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE L KING', 18)}}的其他基金

A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
  • 批准号:
    10511276
  • 财政年份:
    2022
  • 资助金额:
    $ 16.44万
  • 项目类别:
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
  • 批准号:
    10709518
  • 财政年份:
    2022
  • 资助金额:
    $ 16.44万
  • 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
  • 批准号:
    10543994
  • 财政年份:
    2021
  • 资助金额:
    $ 16.44万
  • 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
  • 批准号:
    10372462
  • 财政年份:
    2021
  • 资助金额:
    $ 16.44万
  • 项目类别:
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy
丙酮酸激酶 M2 水平和激活作为糖尿病肾病的保护因素
  • 批准号:
    9235747
  • 财政年份:
    2016
  • 资助金额:
    $ 16.44万
  • 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
  • 批准号:
    10320034
  • 财政年份:
    2016
  • 资助金额:
    $ 16.44万
  • 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
  • 批准号:
    10543746
  • 财政年份:
    2016
  • 资助金额:
    $ 16.44万
  • 项目类别:
Identification of Retinoid-Binding Protein 3 (RBP3): A Protective Factor against Diabetic Retinopathy Using Retina from People with Extreme Duration of Diabetes
类维生素A结合蛋白3 (RBP3)的鉴定:利用糖尿病病程极长的人的视网膜来鉴定糖尿病视网膜病变的保护因子
  • 批准号:
    9006846
  • 财政年份:
    2016
  • 资助金额:
    $ 16.44万
  • 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
  • 批准号:
    8922182
  • 财政年份:
    2011
  • 资助金额:
    $ 16.44万
  • 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
  • 批准号:
    8241364
  • 财政年份:
    2011
  • 资助金额:
    $ 16.44万
  • 项目类别:

相似国自然基金

基于GSTO1介导ASC去谷胱甘肽化修饰研究四妙丸对高尿酸血症血管内皮功能障碍的作用机制
  • 批准号:
    82305034
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于线粒体能量代谢及微循环障碍的多参数MR诊断和预测心脏移植物血管病研究
  • 批准号:
    82371903
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
意识障碍康复的神经血管跨模态信息耦合预测-评估模型与自适应调控策略
  • 批准号:
    62376190
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
工程化细胞外囊泡减轻海马神经干细胞衰老治疗血管性认知障碍的作用及机制研究
  • 批准号:
    82301553
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ALKBH1缺失介导的线粒体功能障碍促进低氧诱导的肺动脉高压肺血管重塑的机制研究
  • 批准号:
    82370066
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目

相似海外基金

Local Vasoconstriction in Postural Tachycardia Syndrome
姿势性心动过速综合征的局部血管收缩
  • 批准号:
    7089833
  • 财政年份:
    2004
  • 资助金额:
    $ 16.44万
  • 项目类别:
Local Vasoconstriction in Postural Tachycardia Syndrome
姿势性心动过速综合征的局部血管收缩
  • 批准号:
    6820293
  • 财政年份:
    2004
  • 资助金额:
    $ 16.44万
  • 项目类别:
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
  • 批准号:
    6773108
  • 财政年份:
    2004
  • 资助金额:
    $ 16.44万
  • 项目类别:
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
  • 批准号:
    6883927
  • 财政年份:
    2004
  • 资助金额:
    $ 16.44万
  • 项目类别:
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
  • 批准号:
    7035329
  • 财政年份:
    2004
  • 资助金额:
    $ 16.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了